The report " Global Bovine Mastitis Market, By Type (Clinical, and Sub-Clinical), By Product (Antibiotics, and Others), By Route of Administration (Intramammary, and Systemic), By Therapy (Lactating Period and Dry Period (Antibiotics, and Others)) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Global Forecast till 2029”.
Key Highlights:
• In October 2018, Boehringer Ingelheim International GmbH introduced a new product for prevention of immunotherapy infections in dairy cattle the company introduced ‘Lockout,’ a blue colored non antibiotic internal teat sealant used for prevention of further intra-mammary infections in cattle.
• In August 2019, Elanco announced the agreement to acquire Bayer’s Animal Health Business, which will together provide both the companies a strong platform for the development of novel treatments for bovine mastitis.
Key Market Insights from the report:
The global bovine mastitis market accounted for US$ 1.3 billion in 2020 and is estimated to be US$ 2.1 billion by 2029 and is anticipated to register a CAGR of 5.3%. The market report has been segmented on the basis of product, application, end user and region.
• Depending upon type, clinical segment dominates the market due to the rising technology and the increasing demand for various indications.
• Depending upon route of administration the market is segmented into intramammary, and systemic.
• Based on therapy the market is segmented into lactating period and dry period.
• By region, North America dominates the global plasma fractionation market in terms of revenue as compared to other regions for the fact that every year there is an increasing demand. The presence of large scale companies in this region will not just aid the growth of the regional market, but will also influence the growth of the global market. As of 2019, the market in North America was worth 0.40 billion and this value is projected to increase at a considerable pace in the coming years. The market in Europe will derive growth from the increasing number of company collaborations, aimed at the development of innovative treatment options for bovine mastitis in several countries including France, Germany, and the UK.
To know the upcoming trends and insights prevalent in this market, click the link below:
https://www.prophecymarketinsights.com/market_insight/Global-Bovine-Mastitis-Market-4530
Competitive Landscape:
The prominent player operating in the global market includes Zoetis, Merck & Co., Inc. (MSD Animal Health), Boehringer Ingelheim International GmbH, Bayer AG, Elanco, Ceva, West Way Health.
The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.
Contact Us:
Sales
Prophecy Market Insights
Email- [email protected]